๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations

โœ Scribed by Katherine L. Widnell; Cynthia Comella


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
132 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

โœฆ Synopsis


Although levodopa remains the most effective drug for the symptomatic treatment of Parkinson's disease (PD), there are significant limitations to its chronic use. Growing preclinical and clinical evidence suggests that the severity of motor fluctuations is influenced both by PD severity and pulsatile stimulation of striatal dopamine receptors. Current management of motor fluctuations is based primarily on strategies to prolong the effects of dopaminergic stimulation. This prolongation is accomplished either through the use of long-acting dopaminergic drugs or prolonging of the effects of levodopa. During the past decade, the armamentarium of dopamine agonists increased and agents that prolong the plasma half-life of levodopa became available. Furthermore, recent clinical trials provide evidence-based approaches to improve the management of motor fluctuations in patients with advanced and early PD.


๐Ÿ“œ SIMILAR VOLUMES


Role of surgery in the treatment of moto
โœ Leo Verhagen Metman; Shaun T. O'Leary ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB

When medications no longer provide patients with Parkinson's disease a reasonable quality of life due to the presence of levodopa-associated motor fluctuations and dyskinesias, surgical treatment is often pursued. Numerous studies have examined the antiparkinsonian efficacy of procedures currently a

Melevodopa/carbidopa effervescent formul
โœ Fabrizio Stocchi; Mario Zappia; Valentina Dall'Armi; Jaime Kulisevsky; Paolo Lam ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB

## Abstract Melevodopa hydrochloride plus carbidopa in effervescent tablets (M/C) is a readily soluble antiparkinsonian tablet formulation. A total of 221 patients with Parkinson's disease and motor fluctuations entered a randomized, doubleโ€blind, doubleโ€dummy, controlled parallel group study, whic

Early treatment benefits of ropinirole p
โœ Bonnie P. Hersh; Nancy L. Earl; Robert A. Hauser; Mark Stacy ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 488 KB ๐Ÿ‘ 1 views

A correct balance between endocannabinoid and dopamine-dependent systems is believed to underlie physiological motor control. We measured the levels of the endocannabinoid anandamide in the cerebrospinal fluid of Parkinson's disease (PD) patients. Subjects were divided into three groups: newly diagn

Motor effects of the partial dopamine ag
โœ L. Verhagen Metman; V. H. Sethy; J. R. Roberts; D. Bravi; J. I. Hoff; M. M. Mour ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 480 KB

## Abstract The motor effects of the partial dopamine agonist (โ€“)โ€3โ€(3โ€hydroxyphenyl)โ€Nโ€nโ€propylpiperidine [(โ€“)โ€3โ€PPP, preclamol] were evaluated in nine patients with Parkinson's disease using a doubleโ€blind, placebocontrolled design. (โ€“)โ€3โ€PPP monotherapy had an antiparkinsonian effect in five of